Education about Non-Alcoholic Steatohepatitis (NASH) and the Role of PPAR Agonists

The PanNASH Initiative aims to increase awareness and disseminate knowledge related to NASH as a multisystem disease with a focus on PPAR agonists among the scientific and clinical community, patients and other key stakeholders within the healthcare system and thus improving the lives of millions of patients worldwide.

New this week!

EDITOR OF THE MONTH!

Prof. Sven Francque

Prof. Dr. Sven Francque obtained his MD at the University of Antwerp, Belgium, in 1994 and was subsequently trained in internal medicine and in gastroenterology and hepatology at the Antwerp University Hospital, Belgium and at the Department of …

Latest Research toward the treatment of NASH disease

Knowledge is crucial for healthcare professionals to manage and diagnose patients with NASH and NAFLD. Over the years, we have been increasingly communicating the results achieved by research, showcasing the latest on therapy to diagnosis and management.

LATEST SCIENTIFIC ADVANCES IN NASH, NAFLD & PPAR AGONISTS

UPCOMING NASH EVENTS

AASLD THE LIVER MEETING

COMMENTED ARTICLES

CATEGORIES

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES